Benzinga's Top Initiations

Analysts at Piper Jaffray initiated coverage on shares of Oncolytics Biotech

with an “overweight” rating. The target price range for Oncolytics Biotech is set to $6. Oncolytics Biotech's shares closed at $3.36 on Friday. Sterne Agee initiated coverage on shares of Vera Bradley

with an “underperform” rating. The target price for Vera Bradley is set to $22. Vera Bradley's stock closed at $25.37 on Friday. Citigroup initiated coverage on shares of Health Insurance Innovations

with a “buy” rating. The target price for Health Insurance Innovations is set to $18. Health Insurance Innovations' shares closed at $12.50 on Friday. Analysts at Needham initiated coverage on shares of Medivation

with a “buy” rating. The target price for Medivation is set to $65. Medivation's shares closed at $46.08 on Friday.